Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1996 Jul;74(2):288-90.
doi: 10.1038/bjc.1996.354.

Epidemiological characteristics of myelodysplastic syndrome in a well-defined French population

Affiliations
Free PMC article
Comparative Study

Epidemiological characteristics of myelodysplastic syndrome in a well-defined French population

M Maynadié et al. Br J Cancer. 1996 Jul.
Free PMC article

Abstract

Data on myelodysplastic syndromes (MDS) are seldom collected by cancer registries and unbiased findings from population-based studies remain rare. We report detailed information on MDS in a well-defined French population in the period 1980-1990. The crude incidence rate was 3.2 per 100000 per year and no significant change in incidence was noted in the study period. The sex ratio was 1.9 and the male predominance was present in all age groups. We observed a rise in incidence after 60 years of age but no significant change in incidence of MDS as a whole was observed over the period studied. Refractory anaemia with excess of blasts (RAEB) was the most frequent subtype. Overall 5 year transformation rate of MDS was 31% (+/- 4%) but it was 100% in RAEB in transformation. The observed 5 year survival rate was 23% +/- 3% and the corresponding corrected rate was 33%. The prognosis of RAEB in transformation was worse than the prognosis of other subtypes (P < 0.01). Discrepancies with epidemiological data from other European countries are discussed.

PubMed Disclaimer

References

    1. Br J Haematol. 1982 Jun;51(2):189-99 - PubMed
    1. Br J Haematol. 1984 Jul;57(3):423-30 - PubMed
    1. Br J Cancer. 1986 Jun;53(6):811-5 - PubMed
    1. Br J Haematol. 1987 Jan;65(1):101-6 - PubMed
    1. Br J Haematol. 1987 Jan;65(1):73-81 - PubMed

Publication types